What was recalled
This page synthesizes the FDA-CVM Sample Collection Compliance Manual (CPG 690.800) framework as it has evolved across 2010-2024. The Compliance Policy Guide structure: FDA Compliance Policy Guides establish FDA enforcement positions on regulatory matters supporting consistent enforcement across FDA personnel and regulated parties. CPG 690.800 specifically addresses sample collection procedures supporting regulatory sampling and analytical testing of pet food and animal feed.
The framework components: (i) sample collection procedures — standardized procedures for collecting representative samples from manufacturing facilities, distribution channels, or retail locations supporting analytical testing; (ii) sample handling standards — temperature control, packaging requirements, shipping standards, and storage requirements supporting sample integrity through analytical testing; (iii) chain-of-custody documentation — comprehensive documentation supporting evidentiary integrity for regulatory enforcement actions; (iv) analytical method standards — FDA-recognized analytical methods supporting consistent analytical results across regulatory analytical laboratories including the Vet-LIRN laboratory network; (v) result interpretation — standardized result interpretation supporting consistent regulatory enforcement decisions across analytical findings.
The operational framework: CPG 690.800 operates through FDA-CVM personnel training, state regulatory authority coordination through the FSAS framework, and Vet-LIRN laboratory network coordination. The framework supports consistent regulatory sampling and analytical testing across federal and state regulatory authorities supporting the broader regulatory framework function including inspection-driven sampling (sampling triggered by facility inspection findings), surveillance-driven sampling (sampling triggered by surveillance signal detection), and recall-driven sampling (sampling supporting recall scope determination).
Why it was recalled
The structural concerns have three layers. Layer one — consistent regulatory sampling and analytical testing supports consistent regulatory enforcement: the framework supports consistent regulatory enforcement across federal and state regulatory authorities, supporting the broader regulatory framework function. Pre-CPG-690.800 regulatory sampling had variability across regulatory authorities and analytical laboratories; the framework addresses this variability through standardized procedures and analytical method standards.
Layer two — chain-of-custody documentation supports evidentiary integrity: regulatory enforcement actions including warning letters, recall coordination, and import alerts require evidentiary integrity supporting enforcement decisions. The chain-of-custody documentation framework supports evidentiary integrity through comprehensive documentation of sample collection, handling, shipping, storage, and analytical testing.
Layer three — analytical method standards support analytical result consistency: analytical method variability across regulatory analytical laboratories would compromise regulatory enforcement consistency; the framework addresses this through FDA-recognized analytical methods supporting consistent results across the Vet-LIRN laboratory network and other regulatory analytical laboratories. Related framework pages: FDA-CVM Form 483 framework, FDA-CVM compliance policy guide framework, FDA Vet-LIRN framework.
Health risks for your pet
Direct health risks of the CPG 690.800 framework are minimal — the framework establishes procedural standards supporting regulatory sampling and analytical testing rather than altering substantive food-safety regulation. Indirect benefits: consistent regulatory sampling and analytical testing supports consistent regulatory enforcement and the broader regulatory framework function. The aggregate framework: CPG 690.800 is a substantive regulatory procedural framework supporting the broader pet food regulatory framework function.
The operational context: CPG 690.800 operates within the broader regulatory framework architecture including FDA-CVM inspection framework, AAFCO Federal-State Audit Standard cooperative framework, Vet-LIRN laboratory network, and state regulatory authority engagement. The integrated architecture supports comprehensive regulatory framework function across the pet food regulated population. Related framework: AAFCO FSAS framework, AAFCO-FDA-CVM joint regulatory authority.
What to do if you bought affected product
Pet owners interested in regulatory sampling and analytical testing frameworks can take several practical approaches: (1) recognize that pet food is subject to regulatory sampling and analytical testing supporting consistent regulatory enforcement — the CPG 690.800 framework supports consistent procedures across federal and state regulatory authorities; (2) review FDA recall announcements for product-specific information — recall announcements typically include analytical testing findings supporting recall scope and consumer guidance; (3) recognize that regulatory testing results inform regulatory enforcement decisions — testing findings drive warning letters, recall coordination, import alerts, and other regulatory enforcement actions; (4) for individual product concerns the manufacturer is the typical first contact — manufacturers conduct internal quality testing supporting product-specific concern resolution; FDA-CVM contact follows if manufacturer-level resolution is not achieved; (5) review broader regulatory framework cluster per the FDA-CVM Form 483 framework, FDA-CVM compliance policy guide framework, and FDA Vet-LIRN framework.
How this affects KibbleIQ’s grade
The KibbleIQ rubric v15 evaluates ingredient quality, nutrient profile, and processing approach per our published methodology. The CPG 690.800 framework affects regulatory procedural standards rather than substantive food-safety regulation; the rubric is unaffected by CPG 690.800 but our consumer-facing presentation incorporates regulatory framework signals where data permits. The framework is covered across our FDA-CVM Form 483 framework and related pages.